Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits In the article that accompanies this ...
Monoaminergic drugs are considered first-line treatment for major depressive disorder (MDD) but can take eight weeks or longer to achieve a response (defined as ≥50% symptom improvement) [1]. Symptom ...
Professor Yeonhee Park of the Department of Statistics at Sungkyunkwan University has developed a novel statistical framework — MARGO (Machine Learning-Assisted Adaptive Randomization for Group ...
Metastatic castration-resistant prostate cancer (mCRPC) is a genetically and clinically heterogeneous disease that can be treated with different classes of systemic agents, such as androgen receptor ...
Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes Adequately prioritizing the numerous therapies and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results